Skip to main content
TipRanks
Go Ultimate75% OFF

Adimmune Corporation (4142) Q4 2023 Earnings Report

TW:4142 Q4 2023 EPS Results

Actual EPS
-TWD 0.98
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
TWD 0.14

TW:4142 Q4 2023 Revenue Results

Actual Revenue
TWD 559.49M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-4.30%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/13/2024
Time
TBA
Conference Call
Wednesday, March 13, 2024

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:4142 Earnings History

TW:4142 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)-0.040.47-0.041193.02% (+0.51)
Aug 05, 20262026 (Q2)―-0.38-0.5226.78% (+0.14)
May 13, 20262026 (Q1)―-0.44-0.5316.98% (+0.09)
Mar 11, 20262025 (Q4)―0.52-0.12554.78% (+0.64)
Nov 12, 20252025 (Q3)―-0.040.61-107.05% (-0.65)
Aug 08, 20252025 (Q2)―-0.52-0.6520.15% (+0.13)
May 13, 20252025 (Q1)-0.65-0.53-0.44-21.56% (-0.09)
Mar 12, 20252024 (Q4)0.21-0.12-0.9888.29% (+0.87)
Nov 14, 20242024 (Q3)―0.610.63-2.56% (-0.02)
Aug 14, 20242024 (Q2)―-0.65-0.57-13.84% (-0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed